Followers | 247 |
Posts | 49914 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Saturday, August 26, 2023 12:51:16 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent SNSE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:37:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:44:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:31:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:28:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:31:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:14:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:40:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 12:35:55 PM
- Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/07/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 11:07:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:17 PM
- Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting • GlobeNewswire Inc. • 11/03/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:53:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:50:13 PM
- Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer • GlobeNewswire Inc. • 11/01/2023 11:30:00 AM
- Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting • GlobeNewswire Inc. • 10/25/2023 01:05:00 PM
- Sensei Biotherapeutics Presents Trial-in-Progress Poster for Phase 1/2 Clinical Study of SNS-101 at ESMO 2023 • GlobeNewswire Inc. • 10/23/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 09:01:02 PM
- Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo® • GlobeNewswire Inc. • 09/27/2023 11:30:00 AM
- Sensei Biotherapeutics Presents New Preclinical Data Reinforcing SNS-101 Pharmacokinetic Profile, Safety Characteristics and Mechanism of Action at the Seventh CRI-ENCI-AACR International Cancer Immunotherapy Conference • GlobeNewswire Inc. • 09/21/2023 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 12:43:31 PM
- Sensei Biotherapeutics to Present New Preclinical Data Supporting Mechanism of Action, Pharmacokinetic Profile and Safety Characteristics for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Seventh CRI-ENCI-AACR International Cancer Immunot • GlobeNewswire Inc. • 09/13/2023 11:30:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM